These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7692532)

  • 1. Spantide-induced antinociception in the opioid mechanism.
    Tan-No K; Sakurada T; Yamada T; Sakurada S; Kisara K
    Regul Pept; 1993 Jul; 46(1-2):343-5. PubMed ID: 7692532
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
    Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of opioid receptors in the antinociception produced by intracerebroventricularly administered spantide in mice.
    Tan-No K; Sakurada T; Yamada T; Sakurada S; Kisara K
    Neuropeptides; 1995 Nov; 29(5):293-9. PubMed ID: 8587665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of spinal opioid receptors in the antinociceptive interactions between intrathecal morphine and bupivacaine.
    Tejwani GA; Rattan AK; McDonald JS
    Anesth Analg; 1992 May; 74(5):726-34. PubMed ID: 1314527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain.
    Goettl VM; Larson AA
    Neuroscience; 1994 May; 60(2):375-82. PubMed ID: 7521022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
    Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
    Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.
    Ochi T; Fujii T; Motoyama Y; Goto T
    Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of intrathecal midazolam on morphine-induced antinociception in the rat: role of spinal opioid receptors.
    Rattan AK; McDonald JS; Tejwani GA
    Anesth Analg; 1991 Aug; 73(2):124-31. PubMed ID: 1649558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Ohba M; Kisara K; Terenius L
    Regul Pept; 1993 Jul; 46(1-2):326-8. PubMed ID: 7692527
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for a supraspinal mechanism in the opioid-mediated antinociceptive effect of ketamine.
    Baumeister A; Advokat C
    Brain Res; 1991 Dec; 566(1-2):351-3. PubMed ID: 1814555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice.
    Sakurada T; Katsumata K; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1993 Sep; 242(1):47-52. PubMed ID: 7693495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

  • 14. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between serotonin and substance P in the spinal regulation of nociception.
    Eide PK; Hole K
    Brain Res; 1991 Jun; 550(2):225-30. PubMed ID: 1715803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal oxymetazoline does not produce neurotoxicity in the spinal cord of the rat.
    Loomis CW; Vyas D; Sherman SE
    Brain Res; 1992 Dec; 599(1):73-82. PubMed ID: 1283563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of an opioid-mediated antinociceptive mechanism in transgenic mice over-expressing substance P in the spinal cord.
    McLeod AL; Ritchie J; Cuello AC; Julien JP; Henry JL; Ribeiro-da-Silva A
    Neuroscience; 2000; 96(4):785-9. PubMed ID: 10727796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.